lorglumide has been researched along with Anorexia in 1 studies
lorglumide: RN given refers to (+-)-isomer
lorglumide : A racemate comprising equal amounts of (R)- and (S)-lorglumide.
N(2)-(3,4-dichlorobenzoyl)-N,N-dipentyl-alpha-glutamine : A dicarboxylic acid monoamide obtained by formal condensation of the alpha-carboxy group of N-(3,4-dichlorobenzoyl)glutamic acid with the amino group of dipentylamine.
Anorexia: The lack or loss of APPETITE accompanied by an aversion to food and the inability to eat. It is the defining characteristic of the disorder ANOREXIA NERVOSA.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Orio, L | 1 |
| Crespo, I | 1 |
| López-Moreno, JA | 1 |
| Reyes-Cabello, C | 1 |
| Rodríguez de Fonseca, F | 1 |
| Gómez de Heras, R | 1 |
1 other study available for lorglumide and Anorexia
| Article | Year |
|---|---|
Additive effects of cannabinoid CB1 receptors blockade and cholecystokinin on feeding inhibition.
Topics: Animals; Anorexia; Benzoxazines; Brain; Drug Synergism; Feeding Behavior; Gene Expression; Genes, fo | 2011 |